BIOMARKER:

CD79B mutation

Entrez ID:

Related biomarkers:

‹

›

CD79B mutation CD79B mutation	Lymphoma Lymphoma	CD79B mutation CD79B mutation	Lymphoma Lymphoma	ibrutinib Sensitive: C2 – Inclusion Criteria	ibrutinib Sensitive: C2 – Inclusion Criteria
CD79B mutation CD79B mutation	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	CD79B mutation CD79B mutation	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	ibrutinib Sensitive: C2 – Inclusion Criteria	ibrutinib Sensitive: C2 – Inclusion Criteria
CD79B mutation CD79B mutation	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	CD79B mutation CD79B mutation	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	zanubrutinib Sensitive: C2 – Inclusion Criteria	zanubrutinib Sensitive: C2 – Inclusion Criteria
CD79B mutation CD79B mutation	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	CD79B mutation CD79B mutation	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	JNJ-67856633 Sensitive: D – Preclinical	JNJ-67856633 Sensitive: D – Preclinical
CD79B mutation CD79B mutation	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	CD79B mutation CD79B mutation	Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma	venetoclax + ibrutinib Sensitive: D – Preclinical	venetoclax + ibrutinib Sensitive: D – Preclinical